BiosensIC ApS: Financial statements 2023
CVR: 41757884
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BiosensIC ApS (CVR 41757884) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,388 and a net result of DKK -18,396 compared with DKK -18,617 the year before. Equity in the 2023 report amounted to DKK -35,622.
- Revenue
- DKK 0
- Gross Profit
- DKK -2,388
- Profit/Loss
- DKK -18,396
- Equity
- DKK -35,622
- Total Assets
- DKK 26,388
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -2 t. | -18 t. | -36 t. | - |
| 2022 | - | -2 t. | -19 t. | -17 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BiosensIC ApS has published its annual report for 2022. Gross profit came to DKK -1,787, and the net result was DKK -18,617.
About BiosensIC ApS
BiosensIC ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Allan Nogueras Nielsen and Leiying Zhu. The company is owned by Allan Nogueras Nielsen and Leiying Zhu. In 2025, the company reported a gross profit of DKK -12,099 and a net result of DKK -13,647 compared with DKK -5,629 the year before. Equity in the 2025 report amounted to DKK -54,898.